Metformin Reduces the Incidence of Open Angle Glaucoma

Metformin and Glaucoma

Glaucoma is the second leading cause of blindness in the world. A medical group submitted a report to Life Extension Magazine® that provides persuasive data that the AMPK-activating drug metformin may be of significant benefit in protecting the eyes against the threat of blindness from open angle glaucoma.

This report is written with some technical language that may make it challenging for some of our readers to understand. We choose to publish it with the caveat that a succinct practical suggestion on how to use metformin to potentially reduce glaucoma risk be made in the introduction.

Read the full report here.